ArticlemedRxiv : the preprint server for health sciences2025
Effect of Injectable Dual and Single Agonist Glucagon-Like Peptide-1 Based Therapy on Inflammatory Bowel Disease Activity Among Patients with Obesity.
Jake Levine et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.